UnicoCell Biomed Co., Ltd. (TPE:6794)
Taiwan
· Delayed Price · Currency is TWD 81.30
-0.30 (-0.37%)
Apr 29, 2026, 1:30 PM CST
UnicoCell Biomed Balance Sheet
Financials in millions TWD. Fiscal year is January - December.
Millions TWD. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2017 |
|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | 2020 - 2017 |
| Cash & Equivalents | 40.84 | 9.57 | 19.9 | 53.64 | 130.85 | Upgrade
|
| Short-Term Investments | 692.08 | 518.37 | 457.38 | 160.25 | 10.17 | Upgrade
|
| Trading Asset Securities | 13.35 | 22.3 | - | - | - | Upgrade
|
| Cash & Short-Term Investments | 746.27 | 550.24 | 477.28 | 213.89 | 141.02 | Upgrade
|
| Cash Growth | 35.63% | 15.29% | 123.15% | 51.67% | -39.24% | Upgrade
|
| Accounts Receivable | 3.19 | 2.81 | 2.08 | 1.38 | 0.4 | Upgrade
|
| Other Receivables | 19.37 | 19.6 | 18.08 | 13.47 | 12.02 | Upgrade
|
| Receivables | 22.55 | 22.41 | 20.16 | 14.84 | 12.42 | Upgrade
|
| Inventory | 9.27 | 9.75 | 7.5 | 7.98 | 7.83 | Upgrade
|
| Prepaid Expenses | 3.31 | 3.66 | 1.61 | 1.13 | 2.04 | Upgrade
|
| Other Current Assets | 5.75 | 6.29 | 0.24 | 0.06 | - | Upgrade
|
| Total Current Assets | 787.16 | 592.35 | 506.8 | 237.9 | 163.31 | Upgrade
|
| Property, Plant & Equipment | 138.04 | 152.59 | 175.89 | 173.36 | 131.21 | Upgrade
|
| Long-Term Investments | 17.26 | 29 | - | - | - | Upgrade
|
| Other Intangible Assets | 0.26 | 0.34 | 0.33 | 0.36 | 0.4 | Upgrade
|
| Other Long-Term Assets | 3.29 | 3.61 | 2.92 | 2.7 | 2.8 | Upgrade
|
| Total Assets | 946.01 | 777.89 | 685.93 | 414.31 | 297.71 | Upgrade
|
| Accounts Payable | 1.23 | 1.97 | 0.11 | 0.91 | 0.08 | Upgrade
|
| Current Portion of Leases | 6.35 | 6.22 | 6.09 | 5.93 | 8.95 | Upgrade
|
| Current Unearned Revenue | 1.1 | 6.62 | 0.02 | 1.52 | - | Upgrade
|
| Other Current Liabilities | 12.06 | 12.32 | 10.68 | 8.18 | 12.34 | Upgrade
|
| Total Current Liabilities | 20.73 | 27.13 | 16.9 | 16.54 | 21.37 | Upgrade
|
| Long-Term Leases | 55.67 | 62.02 | 68.24 | 60.66 | 12.63 | Upgrade
|
| Other Long-Term Liabilities | 4.18 | 4.13 | 4.35 | 3.26 | 0.71 | Upgrade
|
| Total Liabilities | 80.58 | 93.28 | 89.49 | 80.46 | 34.71 | Upgrade
|
| Common Stock | 636.37 | 584.11 | 556.85 | 423.61 | 377.75 | Upgrade
|
| Additional Paid-In Capital | 961.01 | 705.87 | 551.89 | 338.43 | 222.29 | Upgrade
|
| Retained Earnings | -720.2 | -605.37 | -512.29 | -428.19 | -337.03 | Upgrade
|
| Comprehensive Income & Other | -11.74 | - | - | - | - | Upgrade
|
| Shareholders' Equity | 865.44 | 684.61 | 596.44 | 333.85 | 263.01 | Upgrade
|
| Total Liabilities & Equity | 946.01 | 777.89 | 685.93 | 414.31 | 297.71 | Upgrade
|
| Total Debt | 62.02 | 68.24 | 74.33 | 66.59 | 21.58 | Upgrade
|
| Net Cash (Debt) | 684.25 | 482.01 | 402.95 | 147.3 | 119.44 | Upgrade
|
| Net Cash Growth | 41.96% | 19.62% | 173.56% | 23.32% | -39.71% | Upgrade
|
| Net Cash Per Share | 11.24 | 8.40 | 7.49 | 3.55 | 3.17 | Upgrade
|
| Filing Date Shares Outstanding | 63.64 | 58.41 | 55.69 | 42.36 | 37.78 | Upgrade
|
| Total Common Shares Outstanding | 63.64 | 58.41 | 55.69 | 42.36 | 37.78 | Upgrade
|
| Working Capital | 766.43 | 565.22 | 489.9 | 221.36 | 141.94 | Upgrade
|
| Book Value Per Share | 13.60 | 11.72 | 10.71 | 7.88 | 6.96 | Upgrade
|
| Tangible Book Value | 865.18 | 684.27 | 596.12 | 333.5 | 262.61 | Upgrade
|
| Tangible Book Value Per Share | 13.60 | 11.71 | 10.71 | 7.87 | 6.95 | Upgrade
|
| Machinery | 73.95 | 70 | 67.02 | 65.56 | 60.92 | Upgrade
|
| Construction In Progress | - | - | - | - | 68.3 | Upgrade
|
| Leasehold Improvements | 99.39 | 98.28 | 97.5 | 93.25 | 16.35 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.